Herpes Zoster Acyclovir Dosing
For uncomplicated herpes zoster in immunocompetent adults with normal renal function, acyclovir 800 mg orally five times daily for 7-10 days is the recommended regimen, initiated within 72 hours (ideally within 48 hours) of rash onset. 1
Standard Dosing Regimen
- Acyclovir 800 mg orally every 4 hours, 5 times daily for 7-10 days is the FDA-approved dose for acute herpes zoster treatment 1
- Treatment should be initiated within 72 hours of rash onset for maximum efficacy, with greatest benefit when started within 48 hours 2, 3, 4
- The 800 mg five times daily regimen is superior to lower doses (400 mg five times daily), which showed no significant benefit over placebo 5
Clinical Evidence Supporting This Dose
Multiple randomized controlled trials demonstrate that acyclovir 800 mg five times daily significantly:
- Reduces time to cessation of new lesion formation (p<0.01) 3, 4
- Accelerates loss of vesicles and full crusting (p<0.01 to p=0.03) 2, 3, 4
- Decreases acute pain during treatment (p=0.008 to p=0.03) 2, 3, 4, 5
- Reduces viral shedding duration 2, 5
The benefit is most pronounced when treatment begins within 48 hours of rash onset—patients treated after 48 hours showed no significant hastening of rash healing 3
Renal Dosing Adjustments
For patients with renal impairment, dose modifications are essential 1:
- CrCl >25 mL/min: 800 mg every 4 hours (5 times daily) - no adjustment needed
- CrCl 10-25 mL/min: 800 mg every 8 hours
- CrCl 0-10 mL/min: 800 mg every 12 hours
- Hemodialysis patients: Administer additional dose after each dialysis session 1
Special Populations and Situations
Immunocompromised Patients
- May require intravenous acyclovir 10 mg/kg every 8 hours for severe disease or complications 1, 6
- Oral therapy may be less effective; consider IV route for disseminated disease, encephalitis, or visceral involvement 7, 6
Herpes Zoster Ophthalmicus
- Standard oral acyclovir 800 mg five times daily is appropriate 1
- Some evidence suggests 10-15 mg/kg IV three times daily for VZV encephalitis with ophthalmic involvement 7
- Early studies showed no significant benefit in ophthalmic zoster specifically, though this may reflect timing of treatment initiation 2
Geriatric Patients
- Use standard dosing but monitor renal function closely, as acyclovir plasma concentrations are higher in elderly patients due to age-related renal changes 1
- Dosage reduction required if underlying renal impairment present 1
Critical Pitfalls to Avoid
- Do not use lower doses: The 400 mg five times daily regimen is ineffective for herpes zoster 5
- Do not delay treatment: Efficacy diminishes significantly if started >48 hours after rash onset 3, 4
- Do not use topical acyclovir: Topical therapy is substantially less effective than oral administration 7
- Do not forget hydration: At 800 mg doses, maintain adequate hydration and urine flow 6
- Monitor mental status: High-dose acyclovir can cause neurologic side effects, particularly in renal impairment 6
Duration and Postherpetic Neuralgia
- Standard treatment duration is 7-10 days 1
- While acyclovir reduces acute pain, evidence for prevention of postherpetic neuralgia is mixed—some studies show reduced prevalence in first 3 months post-treatment 5, while others show no significant effect 3
- The primary benefit is modification of acute disease course rather than long-term neuralgia prevention 3, 4